Empowered Funds’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.1K | Hold |
91,234
| – | – | ﹤0.01% | 1742 |
|
|
2025
Q1 | $28.5K | Sell |
91,234
-47,181
| -34% | -$14.7K | ﹤0.01% | 1609 |
|
|
2024
Q4 | $129K | Sell |
138,415
-6,925
| -5% | -$6.47K | ﹤0.01% | 1558 |
|
|
2024
Q3 | $172K | Buy |
145,340
+7,370
| +5% | +$8.7K | ﹤0.01% | 1340 |
|
|
2024
Q2 | $106K | Buy |
137,970
+9,900
| +8% | +$7.62K | ﹤0.01% | 1340 |
|
|
2024
Q1 | $391K | Buy |
128,070
+9,625
| +8% | +$29.4K | 0.01% | 1134 |
|
|
2023
Q4 | $381K | Buy |
118,445
+10,645
| +10% | +$34.3K | 0.01% | 1048 |
|
|
2023
Q3 | $414K | Buy |
107,800
+8,848
| +9% | +$34K | 0.01% | 973 |
|
|
2023
Q2 | $325K | Buy |
+98,952
| New | +$325K | 0.01% | 936 |
|